Molecular cloning and immunogenicity of renal cell carcinoma‐associated antigen G250
暂无分享,去创建一个
R. Brakenhoff | C. Figdor | A. van Bokhoven | G. Adema | E. Oosterwijk | P. Mulders | E. Noessner | R. Brakenhoff | G. Merkx | J. Oosterwijk-Wakka | M. D. de Weijert | J. Vissers | K. Grabmaier
[1] C. Auffray,et al. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. , 2005, European journal of biochemistry.
[2] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[3] S. Larson,et al. Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] S. Fleming. Genetics of kidney tumours. , 1998, Forum.
[5] M. Stifelman,et al. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma. , 1997, Cancer research.
[6] W. Linehan,et al. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients. , 1996, The American journal of pathology.
[7] R. Kettmann,et al. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. , 1996, Genomics.
[8] V. Moreno,et al. Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .
[9] J. Schalken,et al. The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma. , 1995, Seminars in oncology.
[10] R. Kettmann,et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. , 1994, Oncogene.
[11] F. Debruyne,et al. Vaccination with ant‐idiotype antibodies mimicking a renal cell carcinoma‐associated antigen induces tumor immunity , 1994, International journal of cancer.
[12] R. Brakenhoff,et al. Optimization and simplification of expression cloning in eukaryotic vector/host systems. , 1994, Analytical biochemistry.
[13] C. Figdor,et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma- derived tumor-infiltrating lymphocytes , 1994, The Journal of experimental medicine.
[14] G. Riethmüller,et al. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. , 1993, Journal of immunology.
[15] B. Gansbacher,et al. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment. , 1993, Cancer research.
[16] N. Bander,et al. Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] R. V. van Lier,et al. T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways , 1991, European journal of immunology.
[18] M. Kozak. The scanning model for translation: an update , 1989, The Journal of cell biology.
[19] D. Ruiter,et al. Monoclonal antibody G 250 recognizes a determinant present in renal‐cell carcinoma and absent from normal kidney , 1986, International journal of cancer.
[20] G. Shaw,et al. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.
[21] R. Vessella,et al. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens. , 1985, Cancer research.
[22] B. Hoffman,et al. A simple and very efficient method for generating cDNA libraries. , 1983, Gene.
[23] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[24] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[25] F. Waldman,et al. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. , 1996, Cancer research.
[26] A. Belldegrun,et al. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity. , 1988, Cancer research.